Evidence map›Paper›PMID 19623177›Full record

ArticleBritish journal of cancer2009

MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

J R McDaid, J Loughery, P Dunne, J C Boyer, C S Downes, R A Farber, C P Walsh

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Genetic Variation ofInternational journal of dentistry · 2026
    Article
  3. Review
  4. Article
  5. Diagnostics (Basel, Switzerland) · 2021
    Review
  6. Journal of Cancer · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

J R McDaidStem Cells and Epigenetics Research Group, Centre for Molecular Biosciences, School of Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, Northern Ireland, UK.
J Loughery
P Dunne
J C Boyer
C S Downes
R A Farber
C P Walsh
University of Ulster · GBUniversity of North Carolina at Chapel Hill · US

Funding

INSTABILITY OF MICROSATELLITES IN MAMMALIAN CELLSR01CA063264 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI FARBER, ROSANN ALEXANDER · 1995 to 2004
$1.5M
Biotechnology and Biological Sciences Research CouncilNCI NIH HHS CA63264NCI NIH HHS R01 CA063264Wellcome Trust
6 · The paper itself

Abstract

backgroundMethylating agents such as N-methyl-N-nitrosourea (MNU) can cause cell cycle arrest and death either via caspase-dependent apoptosis or via a poly(ADP-ribose) polymerase (PARP)-dependent form of apoptosis. We wished to investigate the possible role of MLH1 in signalling cell death through PARP.

methodsFibroblasts are particularly dependent on a PARP-mediated cell death response to methylating agents. We used hTERT-immortalised normal human fibroblasts (WT) to generate isogenic MLH1-depleted cells, confirmed by quantitative PCR and western blotting. Drug resistance was measured by clonogenic and cell viability assays and effects on the cell cycle by cell sorting. Damage signalling was additionally investigated using immunostaining.

resultsMLH1-depleted cells were more resistant to MNU, as expected. Despite having an intact G(2)/M checkpoint, the WT cells did not initially undergo cell cycle arrest but instead triggered cell death directly by PARP overactivation and nuclear translocation of apoptosis-inducing factor (AIF). The MLH1-depleted cells showed defects in this pathway, with decreased staining for phosphorylated H2AX, altered PARP activity and reduced AIF translocation. Inhibitors of PARP, but not of caspases, blocked AIF translocation and greatly decreased short-term cell death in both WT and MLH1-depleted cells. This MLH1-dependent response to MNU was not blocked by inhibitors of ATM/ATR or p53.

conclusionThese novel data indicate an important role for MLH1 in signalling PARP-dependent cell death in response to the methylating agent MNU.

Indexed as

Adaptor Proteins, Signal TransducingAlkylating AgentsApoptosisAtaxia Telangiectasia Mutated ProteinsCaspasesCell CycleCell Cycle ProteinsCell Line, TumorCell SurvivalDNA-Binding ProteinsHistonesHumansIsoquinolinesMethylnitrosoureaMutL Protein Homolog 1Nuclear Proteins3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinoneAdaptor Proteins, Signal TransducingAlkylating AgentsAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanCaspasesCell Cycle ProteinsDNA-Binding ProteinsH2AX protein, humanHistonesIsoquinolinesMethylnitrosoureaMLH1 protein, humanMutL Protein Homolog 1Nuclear ProteinsPiperidinesPoly(ADP-ribose) PolymerasesProtein Serine-Threonine KinasesTelomeraseTERT protein, humanThioguanineTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID19623177
PMCPMC2720233
OpenAlexW2060815936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.